Recurrent Idiopathic Thrombotic Thrombocytopenic Purpura: A Role for Vaccination in Disease Relapse?

American Journal of Kidney Diseases

Volumn 48, Issue 3, 2006, Pages

  Brodin Sartorius, Albane ^a   Guebre Egziabher, Fitsum ^a   Fouque, Denis ^a   Cozon, Gregoire ^a   Villar, Emmanuel ^a   Laville, Maurice ^a   Juillard, Laurent ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

ADAMTS 13 protease; ADAMTS 13 protease autoantibodies; influenza vaccination; Plasma exchange; thrombotic microangiopathy; thrombotic thrombocytopenic purpura

Indexed keywords

AUTOANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FLUVIRINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; REVAXIS; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DIPHTHERIA; DISEASE SEVERITY; HUMAN; INFLUENZA; LONG TERM CARE; MALE; PERTUSSIS; PLASMAPHERESIS; RECURRENT DISEASE; RELAPSE; REMISSION; SHORT COURSE THERAPY; SPLENECTOMY; STREPTOCOCCUS INFECTION; TETANUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TREATMENT RESPONSE; VACCINATION; VACCINATION REACTION;

ADAM PROTEINS; ANTIBODY FORMATION; AUTOANTIBODIES; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; SPLENECTOMY;

EID: 33747337279     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.04.090     Document Type: Article

References (15)

1. Furlan M., Robles R., Galbusera M., et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 (1998) 1578-1584
2. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
3. Moake J.L. Unusually large plasma factor VIII. von Willebrand factor multimers in chronic relapsing Thrombotic thrombocytopenic purpura. N Engl J Med 307 (1982) 1432-1435
4. Tsai H.M. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 14 (2003) 1072-1081
5. Mayer S.A., and Aledort L.M. Thrombotic microangiopathy. Differential diagnosis, pathophysiology and therapeutic strategies. Mt Sinai J Med 72 (2005) 166-175
6. Sadler J.E., Moake J.L., Miyata T., and George J.N. Recent advances in thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program) (2004) 407-423 January
7. Kwaan H.C. Thrombotic thrombocytopenic purpura. A diagnostic and therapeutic challenge. Semin Thromb Hemost 31 (2005) 615-624
8. Frick P.G., and Hitzig W.H. Simultaneous thrombotic thrombocytopenic purpura and agammaglobulinaemia. Lancet 2 (1960) 1401-1402
9. Brown R.C., Blecher T.E., French E.A., and Toghill P.J. Thrombotic thrombocytopenic purpura after influenza vaccination. Br Med J 2 (1973) 303
10. Ramakrishnan N., and Parker L.P. Thrombotic thrombocytopenic purpura following influenza vaccination-A brief case report. Conn Med 62 (1998) 587-588
11. Brain M.C. The haemolytic-uraemic syndrome. Semin Hematol 6 (1969) 162-180
12. Wasserstein A., Hill G., Goldfarb S., and Goldberg M. Recurrent thrombotic thrombocytopenic purpura after viral infection. Clinical and histologic simulation of chronic glomerulonephritis. Arch Intern Med 141 (1981) 685-687
13. Davison A.M., Thomson D., and Robson J.S. Intravascular coagulation complicating influenza A virus infection. Br Med J 1 (1973) 654-655
14. Fakhouri F., Vernant J.P., Veyradier A., et al. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura. A study of 11 cases. Blood 106 (2005) 1932-1937
15. Zheng X., Pallera A.M., Goodnough L.T., Sadler J.E., and Blinder M.A. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab. Ann Intern Med 138 (2003) 105-108